Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease

Raptis DD, Mantzoros CS, Polyzos SA

Therapeutics and Clinical Risk Management 2023, 19:77-96

Published Date: 22 January 2023